Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,847
datasets available to search
ShareScore release 0.9.0
Dataset results
1,847 results for “Psoriasis”
A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis
ClinicalTrials.gov study NCT03733353. IPD Sharing: NO. Countries: 1. Publications: 1.
Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity
ClinicalTrials.gov study NCT02602925. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Local Methotrexate Injections for the Treatment of Nail Psoriasis
ClinicalTrials.gov study NCT06578728. IPD Sharing: NO. Countries: 1. Publications: 14.
LAS41008 in Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT01726933. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
ClinicalTrials.gov study NCT02330380. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03849404. IPD Sharing: UNDECIDED. Countries: 4. Publications: 1.
Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT00710580. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept
ClinicalTrials.gov study NCT00527072. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout t
ClinicalTrials.gov study NCT06333860. IPD Sharing: YES. Countries: 12. Publications: 0.
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
ClinicalTrials.gov study NCT00879944. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
ClinicalTrials.gov study NCT04036435. IPD Sharing: Not stated. Countries: 20. Publications: 3.
Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab
ClinicalTrials.gov study NCT03099083. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis
ClinicalTrials.gov study NCT01901705. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of TNF-α, IL-17A, and YKL-40 in GCF and Serum of Psoriasis Patients and Healthy Controls
ClinicalTrials.gov study NCT06897722. IPD Sharing: UNDECIDED. Countries: 1. Publications: 7.
The Effect of Vitamin D Supplementation on Psoriasis Severity
ClinicalTrials.gov study NCT03334136. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis
ClinicalTrials.gov study NCT00322439. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Efficacy of Roflumilast in the Treatment of Psoriasis
ClinicalTrials.gov study NCT04549870. IPD Sharing: NO. Countries: 1. Publications: 2.
A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT04595409. IPD Sharing: NO. Countries: 4. Publications: 1.
A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis
ClinicalTrials.gov study NCT00320216. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Nicotinamide in the Treatment of Psoriasis
ClinicalTrials.gov study NCT01763424. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.